Fireside chat series

Connect with our National Board Chair: What does it take to outsmart cancer? 
 June 15, 2022 @ 4:30-5 p.m. EST 

Research. The American Cancer Society has invested more than $5 billion in cancer research since 1946, all to find more – and better – treatments, uncover factors that may cause cancer, and improve cancer patients' quality of life. The Society is honored to have given funding to 49 investigators who went on to win the Nobel Prize, considered the highest accolade any scientist can receive. This is a tribute to the Society’s Research program and the strength of its peer-review process. 

Join Michael and ACS Research Professor, Dr. Gregg Semenza, to learn more about the power of the ACS research program.  In 2019, Dr. Semenza and colleagues, Dr. William G. Kaelin Jr. and Sir Peter J. Ratcliffe, were awarded the Nobel Prize “for their discoveries of how cells sense and adapt to oxygen availability.” They identified molecular machinery that regulates the activity of genes in response to varying levels of oxygen.  Dr. Semenza is based at Johns Hopkins University and received his first ACS grant in 2012 to study the role of hypoxia in breast cancer metastasis. He is a ACS Research Professor, which is the most prestigious research grant made by the national program. 

Guest: Dr. Gregg Semenza, Past ACS Research Professor and 2019 Nobel Prize winner 

 


Connect with our National Board Chair: Meet the first ACS Chief Patient Officer
September 14, 2022 @ 4:30-5 p.m. EST  

Join Michael and American Cancer Society Chief Patient Officer, Dr. Arif Kamal, to learn about the Society’s patient-facing activities. Dr. Kamal leads the development and implementation of strategic plans to measurably improve the lives of cancer patients and their families.  Dr. Kamal oversees our Patient Support pillar, which encompasses cancer control, patient navigation, educational programs, patient lodging solutions, transportation services, contact center, and digital patient support offerings, as well all aspects of ACS functions that touch patients across 5,000 communities around the globe.

Guest: Dr. Arif Kamal, ACS Chief Patient Officer

 


Connect with our National Board Chair: Rallying Together to Influence Change 
October 26, 2022 @ 4:30-5 p.m. EST  

If we are to succeed in our mission to end suffering and death from cancer, it won't just happen in the doctor's office or research lab. This movement must start at the statehouse and in Congress.  For 20 years the American Cancer Society Cancer Action Network (ACS CAN) has been empowering volunteers to influence change and impact the future of cancer. From gaining dramatic increases in funding for cancer research to ensuring all Americans have access to cancer care, our work is saving lives and leading to new innovative breakthroughs in how to fight this disease. 

Join Michael and President of the nonpartisan advocacy affiliate of the ACS, Lisa Lacasse, for an insightful discussion about the organization she leads in support of laws and policies that help people fight cancer and advance the ACS’ mission. 

Guest: Lisa Lacasse, President, ACS CAN

 


Connect with our National Board Chair  
December 7, 2022 @ 4:30-5 p.m. EST  

Guest: TBD

 

Connect with our National Board Chair: The American Cancer Society has a Venture Fund?
March 2nd 2022

Michael and Alice engaged in a conversation about how BrightEdge propels groundbreaking patient-centric solutions by investing in the most innovative startup companies to advance science, reduce disparities, and promote health care sustainability.

Guest: Alice Pomponio, Vice President Innovation & Impact Investing / Managing Director, BrightEdge 

Watch the Event Recording


Connect with our National Board Chair: What’s Next for ACS?   
April 20th 2022

Karen and Michael reflected on key mission accomplishments achieved during her first year as CEO and provided insight regarding plans to enhance our organizational impact. 

Guest: Dr. Karen E. Knudsen, CEO, ACS and ACS CAN 

Watch the Event Recording

Upcoming Events

Connect with our National Board Chair: What does it take to outsmart cancer? 
 June 15, 2022 @ 4:30-5 p.m. EST 

Research. The American Cancer Society has invested more than $5 billion in cancer research since 1946, all to find more – and better – treatments, uncover factors that may cause cancer, and improve cancer patients' quality of life. The Society is honored to have given funding to 49 investigators who went on to win the Nobel Prize, considered the highest accolade any scientist can receive. This is a tribute to the Society’s Research program and the strength of its peer-review process. 

Join Michael and ACS Research Professor, Dr. Gregg Semenza, to learn more about the power of the ACS research program.  In 2019, Dr. Semenza and colleagues, Dr. William G. Kaelin Jr. and Sir Peter J. Ratcliffe, were awarded the Nobel Prize “for their discoveries of how cells sense and adapt to oxygen availability.” They identified molecular machinery that regulates the activity of genes in response to varying levels of oxygen.  Dr. Semenza is based at Johns Hopkins University and received his first ACS grant in 2012 to study the role of hypoxia in breast cancer metastasis. He is a ACS Research Professor, which is the most prestigious research grant made by the national program. 

Guest: Dr. Gregg Semenza, Past ACS Research Professor and 2019 Nobel Prize winner 

 


Connect with our National Board Chair: Meet the first ACS Chief Patient Officer
September 14, 2022 @ 4:30-5 p.m. EST  

Join Michael and American Cancer Society Chief Patient Officer, Dr. Arif Kamal, to learn about the Society’s patient-facing activities. Dr. Kamal leads the development and implementation of strategic plans to measurably improve the lives of cancer patients and their families.  Dr. Kamal oversees our Patient Support pillar, which encompasses cancer control, patient navigation, educational programs, patient lodging solutions, transportation services, contact center, and digital patient support offerings, as well all aspects of ACS functions that touch patients across 5,000 communities around the globe.

Guest: Dr. Arif Kamal, ACS Chief Patient Officer

 


Connect with our National Board Chair: Rallying Together to Influence Change 
October 26, 2022 @ 4:30-5 p.m. EST  

If we are to succeed in our mission to end suffering and death from cancer, it won't just happen in the doctor's office or research lab. This movement must start at the statehouse and in Congress.  For 20 years the American Cancer Society Cancer Action Network (ACS CAN) has been empowering volunteers to influence change and impact the future of cancer. From gaining dramatic increases in funding for cancer research to ensuring all Americans have access to cancer care, our work is saving lives and leading to new innovative breakthroughs in how to fight this disease. 

Join Michael and President of the nonpartisan advocacy affiliate of the ACS, Lisa Lacasse, for an insightful discussion about the organization she leads in support of laws and policies that help people fight cancer and advance the ACS’ mission. 

Guest: Lisa Lacasse, President, ACS CAN

 


Connect with our National Board Chair  
December 7, 2022 @ 4:30-5 p.m. EST  

Guest: TBD

 

Past Events

Connect with our National Board Chair: The American Cancer Society has a Venture Fund?
March 2nd 2022

Michael and Alice engaged in a conversation about how BrightEdge propels groundbreaking patient-centric solutions by investing in the most innovative startup companies to advance science, reduce disparities, and promote health care sustainability.

Guest: Alice Pomponio, Vice President Innovation & Impact Investing / Managing Director, BrightEdge 

Watch the Event Recording


Connect with our National Board Chair: What’s Next for ACS?   
April 20th 2022

Karen and Michael reflected on key mission accomplishments achieved during her first year as CEO and provided insight regarding plans to enhance our organizational impact. 

Guest: Dr. Karen E. Knudsen, CEO, ACS and ACS CAN 

Watch the Event Recording